When it comes to cannabis and international trade all transactions are governed by three core UN drug control treaties, and more generally by international trade and investment law. In addition to these UN treaties, the World Trade Organization (WTO) also governs cannabis trade. This includes all cannabis trade, whether recreational or medical. In Canada, the Cannabis Act (Act) governs the international trade of cannabis. A license issued by Health Canada is required to import and/or export cannabis, as well as correlating permits.
Canada was the first of the G20 countries to fully legalize cannabis in the summer of 2018. Since then, Canada has emerged as the dominant exporter in the blossoming global trade of cannabis. With all their provinces undergoing legalization simultaneously, the political support is there to enable Canada to continue to dominate the worldwide Cannabis market. This isn’t because they have the best buds in the world or because their the cheapest either.
Because of the Schedule 1 drug federal status in the US, it is illegal for cannabis to be sold internationally or even interstate. The current retail market for cannabis produced in legal US states is still limited to the confines of the producing state’s borders. The inconsistencies within the US, even between cannabis legal states, has the black market continuing to thrive instead of expanding legal sales and profits. While Oregon is the only legal state so far who has legislation (Senate Bill 582) on the books about transporting cannabis across state borders; cross-border transportation won’t be allowed until the US federal government permits it.
An understandable restriction in OR Senate Bill 582 is that cross-state transportation would only be allowed between states that have legalized. Yet, the possibilities for tremendous growth from within the industry and the trickle-down economic stimulation if cannabis were federally legal in the US is almost incomprehensible. The employment opportunities of a commodity as profitable as cannabis has been proven in the already legal states. A reminder from Veriheal contributor Marcus Quoyeser, “…keep in mind that the true failure is drug policy in the United States.”
Because cannabis grown in legal US states is tightly regulated for safety, we’ve become known for creating higher quality products. Underlying the U.S. Cannabis industry is sophistication and genetics; leading to better-quality and higher-potency flowers. In addition to some of the highest quality plant material, the US also is leading the way in cannabis product varieties.
With the endless sea of potential products, cannabis consumers in legal US states have access to various forms of consumption and delivery method. From flower to concentrates, edibles to tinctures, and topicals to beverages; the US leads the way in product selection. The majority of Canadian cannabis companies were not ready to launch what they are calling Cannabis 2.0. According to Marijuana Business Daily, The Ontario Cannabis Store (OCS) sold out of edibles within hours of initial availability on January 16, 2020. Topicals, concentrates, and beverages are still months away from hitting store shelves in Canada, yet nearly every dispensary in the US has a wide selection.
Recommendations from the Expert Committee on Drug Dependence (ECDD) of the World Health Organization (WHO) were presented to the United Nations Commission on Narcotic Drugs (CND) in January 2019. Mostly welcomed by the industry, the suggestion to remove cannabis from Schedule 4 of the 1961 Convention signals more acknowledgment of medicinal value than what the current scheduling suggests. Countries look to these global organizations when considering legalization. While the market currently remains semi-limited, at least 30 countries — including Mexico, Germany, and Italy — have legalized medical cannabis. The hopeful end result is an open global Cannabis market soon to come.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…
Experts are taking a bird’s eye view of an exciting and rapidly evolving area in cannabis research known as the endocannabinoidome (eCBome)….
Spliffs and joints, while similar, are different cannabis products rolled up in paper. If you are a seasoned cannabis smoker, you’re probably…